Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism

Hirsutism Clinical Trial

Official title: Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism

Status Completed

Clinical Trial Summary

Split-face investigation of the efficacy of applying Eflornithin cream twice daily for six months after a period with six laser treatments for hair removal.

Clinical Trial Description

Background: Unwanted facial hair growth is a serious problem for 5-15% of all women winch affects their quality of life. In Denmark patients are offered six laser treatments covered by the public health insurance. There is a lack of good follow-up treatments to this regime that can extent the efficacy of the laser treatment. Eflornithin cream is an approved treatment for reduction of facial hair growth which has proved to give an additional efficiency when used in combination with laser treatments.The efficacy when used after laser hair removal is not known.

Aim: To investigate whether an extended efficacy of laser hair removal can be achieved with application of Eflornithin cream twice daily for six months after completion of laser treatments.

Method: in a split-face trial to apply Eflornithin cream twice daily for six months. Outcome measures are investigator evaluation, blinded on-site evaluation, patient's assessment score and clinical photos. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Hirsutism

• NCT number: NCT01817894
• Study type: Interventional
• Source: Bispebjerg Hospital
• Status: Completed
• Phase: Phase 4
• Start date: January 2012
• Completion date: October 2013